IN THE NEWS ARCHIVE 2005 2004 2003

2005 Date Publication 11/08/05 Molecular Insight Pharmaceuticals, Inc. Files Registration Statement For Proposed Initial Public Offering 09/26/05 Molecular Insight Pharmaceuticals Announces Publication of Phase 2a Zemiva™ (BMIPP) Trial Results in Circulation 08/18/05 Molecular Insight Expands Executive Research and Development Team 07/21/05 Molecular Insight Pharmaceuticals Announces Management Additions 06/21/05 FierceBiotech Honors Molecular Insight Pharmaceuticals as One of the "Fierce 15" Biotech Companies of 2005 06/01/05 Molecular Insight Pharmaceuticals Appoints Two New Vice Presidents, James Wachholz and Joshua Hamermesh 04/21/05 Molecular Insight Pharmaceuticals Raises $28 Million to Advance Cardiac Ischemia Imaging Pharmaceutical into Phase 3 Trials 2004 Date Publication 08/26/04 Molecular Insight Pharmaceuticals and University of Maryland Share NIH Grant 07/21/04 New Fluorescence-Based Technology Allows Visualization of Cellular Activity of Molecular Imaging Pharmaceutical Candidates 06/29/04 Molecular Insight Pharmaceuticals Augments Research and Development Capability with Key Hire and Appointment of Two New Board Members 06/22/04 Prostate Tumor Angiogenesis Successfully Targeted by Radiopharmaceutical Designed for Diagnosis and Treatment 06/17/04 MDS Nordion to manufacture Molecular Insight’s lead molecular imaging pharmaceutical 05/20/04 Molecular Insight Pharmaceuticals, Inc. Completes Series B Financing 2003 Date Publication 10/16/03 Molecular Insight Pharmaceuticals Awarded Three NIH Grants 06/19/03 Molecular Insight Pharmaceuticals, Inc. Names New CEO Contact: Priscilla Harlan Vice President, Corporate Communications Molecular Insight Pharmaceuticals, Inc. (617) 492-5554